Macrophage Migration Inhibitory Factor and Pulmonary Immunity: a Systems Biology Perspective on Its Role in Lung Diseases
Cellular Physiology and Biochemistry · 29.04.2026 · 60 (2) · 223-244
DOI: 10.33594/000000864 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Physiology and Biochemistry, online erschienen am 29.04.2026. Verfasst von Aliyarbayova Aygun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytology, Embryology and Histology, Azerbaijan Medical University, Baku, Azerbaijan. Hauptthemen laut MEDLINE: Macrophage Migration-Inhibitory Factors, Lung, Lung Diseases.
Abstract (Originalsprache)
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that occupies a central regulatory position within pulmonary immune networks, integrating inflammatory signalling, redox control, and immune stromal communication. Originally characterised as a pro-inflammatory mediator, MIF is now recognised to exert context-dependent functions that range from: protective host defence during acute infection to the promotion of chronic inflammation, fibrosis, and tumour progression when regulatory constraints fail. This review synthesises current evidence on the molecular biology, structural features, and signalling mechanisms governing MIF activity in the lung, emphasising its role as a network hub coordinating CD74/CD44- and CXCR-mediated signalling, glucocorticoid antagonism, and redox imbalance. A systems biology perspective is applied to illustrate how genetic variability, environmental exposure, ageing, and metabolic stress reprogram MIF-centred immune circuits across pulmonary disease states. Integration of multi-omics insights, systems pharmacology, and computational modelling highlights emerging opportunities for the selective modulation of MIF signalling, rather than indiscriminate inhibition. Disease-specific manifestations of MIF dysregulation in pneumonia, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and lung cancer are discussed as dynamic outcomes of shared regulatory architectures. Collectively, this review positions MIF as a critical immunoregulatory node whose context-dependent modulation may support future biomarker development and therapeutic strategies currently under active preclinical investigation in complex pulmonary disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cytology, Embryology and Histology, Azerbaijan Medical University, Baku, Azerbaijan.
- Department of Public Health and Healthcare Organization, Azerbaijan Medical University, Baku, Azerbaijan.
- Department of Pharmaceutical Toxicology and Chemistry, Azerbaijan Medical University, Baku, Azerbaijan.
- Department of Human Anatomy and Medical Terminology, Azerbaijan Medical University, Baku, Azerbaijan.
Zitieren
APA
Aygun, A., Yaqut, H., Sara, P., Guney, Q., Sevda, Q., & Arzu, M. (2026). Macrophage Migration Inhibitory Factor and Pulmonary Immunity: a Systems Biology Perspective on Its Role in Lung Diseases. Cellular Physiology and Biochemistry, 60(2), 223-244. https://doi.org/10.33594/000000864
Vancouver
Aygun A, Yaqut H, Sara P, Guney Q, Sevda Q, Arzu M. Macrophage Migration Inhibitory Factor and Pulmonary Immunity: a Systems Biology Perspective on Its Role in Lung Diseases. Cellular Physiology and Biochemistry. 2026;60(2):223-244. doi:10.33594/000000864
BibTeX
@article{Aygun2026,
author = {Aygun, Aliyarbayova and Yaqut, Hajiyeva and Sara, Pashayeva and Guney, Qaniyeva and Sevda, Qarayeva and Arzu, Mekhtiyeva},
title = {Macrophage Migration Inhibitory Factor and Pulmonary Immunity: a Systems Biology Perspective on Its Role in Lung Diseases},
journal = {Cellular Physiology and Biochemistry},
year = {2026},
volume = {60},
number = {2},
pages = {223--244},
doi = {10.33594/000000864}
}
EUVIMED